Endoluminal therapy for gastroesophageal reflux disease: Is the evidence for efficacy any stronger?

Thomas J. Lee*, Peter J. Kahrilas

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Gastroesophageal reflux disease is a common disorder often requiring chronic treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered US and European markets, claiming effectiveness comparable with antireflux surgery. Nevertheless, a paucity of data is available to support that efficacy, even as more devices are coming onto the market. This review examines published reports of endoluminal reflux therapies from January 2004 to January 2005. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments.

Original languageEnglish (US)
Pages (from-to)202-206
Number of pages5
JournalCurrent gastroenterology reports
Volume7
Issue number3
DOIs
StatePublished - Jun 2005

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'Endoluminal therapy for gastroesophageal reflux disease: Is the evidence for efficacy any stronger?'. Together they form a unique fingerprint.

Cite this